BIXT Message Board Post 26035304 | Bioxytran Inc
home / stock / bixt / bixt message board
steffanhen570
()
Posted on: Aug/31/2023 21:21:27
Bioxytran, Inc. ($BIXT)'s commitment to providing safe and effective treatments for patients suffering from viral infections and hypoxia is admirable. Hypoxia, which is typified by low oxygen levels in the body's tissues, can induce tissue damage and cell death if left untreated. It is heartening to see that Bioxytran is working on medication candidates with the goal of curing this serious sickness. The stock must have 132.03 million or more outstanding shares.
News, Short Squeeze, Breakout and More Instantly...
Bioxytran Inc Company Name:
BIXT Stock Symbol:
Market:
-
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...
-
AIA Group Limited ADR (AAGIY) is expected to report for Q4 2023 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 SecureWorks Corp. (SCWX) is expected to report $-0.15 for Q4 2024 Acacia Research Corporation (ACTG) is expected to report for quarter end...
-
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...